Sebia invites you to their event

Unlocking the power of anti-MCV detection for early diagnosis of Rheumatoid Arthritis

About this event

Learn how crucial these factors are for patient management with Rheumatoid Arthritis.

Early detection. Early treatment.


Traditional tests for Rheumatoid Arthritis (RA) detect the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptide (CCP). But neither test identifies all patients with the disorder, especially in the early stages when intervention can prevent more serious disease later. This session will discuss the role of citrullination in RA, the evolution of anti-CCP assays, and the search for antibodies to individual citrullinated proteins which may be used to complement anti-CCP in the diagnosis and management of RA. The utility of antibody to the mutated version of citrullinated vimentin will be highlighted.


Holger Bang, PhD


Senior Scientific Advisor


Roberto Fiorillo


Global Product Manager Autoimmunity

Hosted by

  • Team member
    Holger Dr. Bang

  • Team member
    Roberto Fiorillo Global Product Manager Autoimmunity


The new language of Life

Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing.